Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10445419rdf:typepubmed:Citationlld:pubmed
pubmed-article:10445419lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10445419lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:10445419lifeskim:mentionsumls-concept:C0032854lld:lifeskim
pubmed-article:10445419lifeskim:mentionsumls-concept:C0302600lld:lifeskim
pubmed-article:10445419lifeskim:mentionsumls-concept:C0085533lld:lifeskim
pubmed-article:10445419lifeskim:mentionsumls-concept:C0746319lld:lifeskim
pubmed-article:10445419lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:10445419lifeskim:mentionsumls-concept:C1561558lld:lifeskim
pubmed-article:10445419pubmed:issue3lld:pubmed
pubmed-article:10445419pubmed:dateCreated1999-9-23lld:pubmed
pubmed-article:10445419pubmed:abstractTextTumoral angiogenesis has been described as associated with poor prognosis in breast cancer, particularly for node negative breast cancer. The purpose of this study was to evaluate the influence of angiogenesis in node-positive breast cancer and particularly its potential impact on adjuvant chemotherapy.lld:pubmed
pubmed-article:10445419pubmed:languageenglld:pubmed
pubmed-article:10445419pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10445419pubmed:citationSubsetIMlld:pubmed
pubmed-article:10445419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10445419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10445419pubmed:statusMEDLINElld:pubmed
pubmed-article:10445419pubmed:monthAprlld:pubmed
pubmed-article:10445419pubmed:issn0167-6806lld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:HassounJJlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:JacquemierJJlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:ViensPPlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:MaraninchiDDlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:HouvenaeghelG...lld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:ResbeutMMlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:CamerloJJlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:GravisGGlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:Penault-Llorc...lld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:BertucciFFlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:BardouV JVJlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:PuigBBlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:Oziel-TaïebSSlld:pubmed
pubmed-article:10445419pubmed:authorpubmed-author:BirbaumDDlld:pubmed
pubmed-article:10445419pubmed:issnTypePrintlld:pubmed
pubmed-article:10445419pubmed:volume54lld:pubmed
pubmed-article:10445419pubmed:ownerNLMlld:pubmed
pubmed-article:10445419pubmed:authorsCompleteYlld:pubmed
pubmed-article:10445419pubmed:pagination205-12lld:pubmed
pubmed-article:10445419pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:meshHeadingpubmed-meshheading:10445419...lld:pubmed
pubmed-article:10445419pubmed:year1999lld:pubmed
pubmed-article:10445419pubmed:articleTitleAssociation of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy.lld:pubmed
pubmed-article:10445419pubmed:affiliationMedical Oncology Department, Institut Paoli Calmettes, Université de la Méditerranée, Marseille, France. oncomed@marseille.fnclcc.frlld:pubmed
pubmed-article:10445419pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10445419pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10445419lld:pubmed